- Home
- ADT vs SRPT Comparison
ADT vs SRPT Comparison
Compare ADT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- SRPT
- Stock Information
- Founded
- ADT 1874
- SRPT 1980
- Country
- ADT United States
- SRPT United States
- Employees
- ADT N/A
- SRPT N/A
- Industry
- ADT Diversified Commercial Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- ADT Consumer Discretionary
- SRPT Health Care
- Exchange
- ADT Nasdaq
- SRPT Nasdaq
- Market Cap
- ADT 6.5B
- SRPT N/A
- IPO Year
- ADT 2018
- SRPT 1997
- Fundamental
- Price
- ADT $8.33
- SRPT $36.27
- Analyst Decision
- ADT Buy
- SRPT Buy
- Analyst Count
- ADT 4
- SRPT 23
- Target Price
- ADT $9.05
- SRPT $131.09
- AVG Volume (30 Days)
- ADT 18.3M
- SRPT 4.0M
- Earning Date
- ADT 04-24-2025
- SRPT 05-06-2025
- Dividend Yield
- ADT 2.64%
- SRPT N/A
- EPS Growth
- ADT N/A
- SRPT N/A
- EPS
- ADT 0.59
- SRPT N/A
- Revenue
- ADT $4,976,265,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- ADT $5.26
- SRPT $64.51
- Revenue Next Year
- ADT $4.62
- SRPT $22.40
- P/E Ratio
- ADT $14.09
- SRPT N/A
- Revenue Growth
- ADT 5.65
- SRPT 59.15
- 52 Week Low
- ADT $6.53
- SRPT $35.46
- 52 Week High
- ADT $8.39
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- ADT 62.26
- SRPT 22.68
- Support Level
- ADT $8.05
- SRPT $35.46
- Resistance Level
- ADT $8.44
- SRPT $64.80
- Average True Range (ATR)
- ADT 0.19
- SRPT 3.78
- MACD
- ADT 0.04
- SRPT -1.64
- Stochastic Oscillator
- ADT 87.01
- SRPT 2.76
About ADT ADT Inc.
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. It offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. The company segments include Consumer and Small Business (CSB), Commercial, and Solar. It generates maximum revenue from the Commercial segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.